Pinz Capital Management’s AnaptysBio ANAB Stock Holding History

Pinz Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,900	Closed	-$187K	–	379
2021 Q3	$187K	Buy	+6,900	New	+$175K	0.08%	96

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Pinz Capital Management's ANAB Position: Q4 2021 in Review

Pinz Capital Management sold out of AnaptysBio (ANAB) in Q4 2021, closing a stake of 6,900 shares — an estimated $187K sold.

Pinz Capital Management first reported a position in ANAB in Q3 2021 and held it in 1 quarter. The position peaked at $187K in Q3 2021. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2021.

Pinz Capital Management reported no remaining AnaptysBio position as of Q4 2021 after selling out during the quarter.
Pinz Capital Management sold 6,900 AnaptysBio shares in Q4 2021, an estimated $187K.
Pinz Capital Management first reported a position in AnaptysBio in Q3 2021 and held it in 1 quarter.
Pinz Capital Management's AnaptysBio position peaked at $187K in Q3 2021.
136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2021.

Based on Pinz Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.